List of Figures
Figure 1-1: Conventional Drug Delivery Systems - Limitations
Figure 1-2: Novel Drug Delivery Platform Diversification
Figure 1-3: Evolution Of Drug Delivery Technology: 1st to 3rd Generation
Figure 1-4: Challenges Addressed By Third Generation Drug Delivery
Figure 1-5: Targeted vs. Non-Targeted Drug Delivery
Figure 1-6: Zero-Order Controlled Drug Release
Figure 1-7: Plasma Concentration-Time Profile: Conventional vs. Controlled Release
Figure 1-8: Comparison Of Modified Drug Release Systems
Figure 1-9: Pulsatile Drug Release Mechanism In Pulsincap
Figure 1-10: Classification By Technical Complexity
Figure 1-11: Structural Differences Among Drug Delivery Systems
Figure 1-12: Classification By Route of Administration
Figure 1-13: Types Of Diffusion-Controlled Mechanisms
Figure 1-14: Encapsulation Dissolution-Controlled Mechanism
Figure 1-15: Osmotic Controlled Drug Release
Figure 1-16: Erosion Mechanisms In Matrix Systems
Figure 2-1: Polymeric Controlled Drug Delivery Devices - Categories
Figure 2--2: Nanostructures For Nanoparticulate Delivery Systems
Figure 3-1: Global - Controlled Release Drug Delivery Market Size (US$ Billion), 2022 - 2025
Figure 3-2: Global - Controlled Release Drug Delivery Market Forecast (US$ Billion), 2026 - 2030
Figure 4-1: Major Non-Invasive Routes For Insulin Delivery
Figure 4-2: Controlled Drug Delivery Strategies In Cancer Therapy
Figure 6-1: Global - Controlled Release Drug Clinical Pipeline By Phase (Number), 2025 Till 2030
Figure 8-1: Namzaric - Price Per Unit & Supply (US$), August’2025
Figure 8-2: Generic Donepezil/Memantine - Price Per Unit & Supply (US$), August’2025
Figure 8-3: Namenda XR - Price Per Unit & Supply Of 7mg & 21mg Extended Release Capsules (US$), August’2025
Figure 8-4: Namenda XR - Price Per Unit & Supply Of 14mg & 28mg Extended Release Capsules (US$), August’2025
Figure 8-5: Namenda XR - Price Per Unit & Supply Of Extended Release Oral Kit (US$), August’2025
Figure 8-6: Generic Memantine - Price Per Unit & Supply Of 7mg & 21mg Extended Release Capsules (US$), August’2025
Figure 8-7: Generic Memantine - Price Per Unit & Supply Of 14mg Extended Release Capsules (US$), August’2025
Figure 8-8: Generic Memantine - Price Per Unit & Supply Of 28mg Extended Release Capsules (US$), August’2025
Figure 8-9: Razadyne ER - Price Per Unit & Supply (US$), August’2025
Figure 8-10: Generic Galantamine - Price Per Unit & Supply (US$), August’2025
Figure 9-1: Gocovri - Price Per Unit & Supply (US$), August’2025
Figure 9-2: Global - Gocovri Annual Sales (US$ Million), 2021-2025
Figure 9-3: Global - Gocovri Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 9-4: Global - Gocovri Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 9-5: Osmolex ER - Price Per Unit & Supply Of 322 mg Extended Release Tablet (US$), August’2025
Figure 9-6: Osmolex ER - Price Per Unit & Supply Of 129 mg Extended Release Tablet (US$), August’2025
Figure 9-7: Osmolex ER - Price Per Unit & Supply Of 193 mg Extended Release Tablet (US$), August’2025
Figure 9-8: Osmolex ER - Price Per Unit & Supply Of 258 mg Extended Release Tablet (US$), August’2025
Figure 9-9: Mirapex ER - Available Dosage Strengths (mg)
Figure 9-10: Mirapex ER - Price Per Unit & Supply Of 0.375 mg & 0.75 mg Extended Release Tablets (US$), August’2025
Figure 9-11: Mirapex ER - Price Per Unit & Supply Of 1.5 mg Extended Release Tablet (US$), August’2025
Figure 9-12: Mirapex ER - Price Per Unit & Supply Of 2.25 mg, 3 mg, 3.75 mg & 4.5 mg Extended Release Tablets (US$), August’2025
Figure 9-13: Generic Pramipexole - Price Per Unit & Supply Of 0.375 mg & 0.75 mg (US$), August’2025
Figure 9-14: Generic Pramipexole - Price Per Unit & Supply Of 1.5 mg, 2.25 mg, 3 mg, & 4.5 mg (US$), August’2025
Figure 9-15: Generic Pramipexole - Price Per Unit & Supply Of 3.75 mg (US$), August’2025
Figure 10-1: Invega - Available Dosage Strengths (mg)
Figure 10-2: Invega - Price Per Unit & Supply (US$), August’2025
Figure 10-3: Invega Sustenna - Price Per Unit & Supply (US$), August’2025
Figure 10-4: Invega Trinza - Price Per Unit & Supply (US$), August’2025
Figure 10-5: Invega Hafyera - Price Per Unit & Supply (US$), August’2025
Figure 10-6: Global - Invega Franchise Annual Sales (US$ Million), 2020-2025
Figure 10-7: Global - Invega Franchise Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 10-8: Global - Invega Franchise Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 10-9: US - Invega Franchise Annual Sales (US$ Million), 2020-2025
Figure 10-10: US - Invega Franchise Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 10-11: US - Invega Franchise Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 10-12: ROW - Invega Franchise Annual Sales (US$ Million), 2020-2025
Figure 10-13: ROW - Invega Franchise Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 10-14: ROW - Invega Franchise Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 10-15: Seroquel XR - Available Dosage Strengths (mg)
Figure 10-16: Seroquel XR - Price Per Unit & Supply (US$), August’2025
Figure 10-17: Generic Quetiapine - Price Per Unit & Supply Of 60 Tablets (US$), August’2025
Figure 10-18: Generic Quetiapine - Price Per Unit & Supply Of 100 Tablets (US$), August’2025
Figure 10-19: Global - Seroquel XR Total Annual Sales (US$ Million), 2020-2021
Figure 10-20: Abilify Maintena - Available Dosage Strengths (mg)
Figure 10-21: Abilify Maintena - Price Per Supply of Vial & Prefilled Syringe (US$), August’2025
Figure 10-22: Abilify Asimtufii - Price Per Unit & Supply (US$), August’2025
Figure 10-23: Global - Abilify Franchise Annual Sales (US$ Million), 2020-2025
Figure 10-24: Global - Abilify Franchise Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 10-25: Global - Abilify Franchise Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 10-26: Aristada - Available Dosage Strengths (mg)
Figure 10-27: Aristada - Price Per Unit & Supply (US$), August’2025
Figure 10-28: Aristada Initio - Price Per Unit & Supply (US$), August’2025
Figure 10-29: Global - Aristada Franchise Annual Sales (US$ Million), 2020-2025
Figure 10-30: Global - Aristada Franchise Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 10-31: Global - Aristada Franchise Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 10-32: Rykindo - Available Dosage Strengths (mg)
Figure 10-33: Rykindo - Price Per Supply (US$), August’2025
Figure 10-34: Generic Risperidone - Price Per Supply (US$), August’2025
Figure 10-35: Risperdal Consta - Price Per Supply (US$), August’2025
Figure 10-36: Global - Risperdal Consta Annual Sales (US$ Million), 2020-2021
Figure 10-37: Uzedy - Price Per Unit & Supply (US$), August’2025
Figure 11-1: Hysingla ER - Available Dosage Strengths (mg)
Figure 11-2: Hysingla ER - Price Per Unit & Supply (US$), August’2025
Figure 11-3: Generic Hydrocodone - Price Per Unit & Supply (US$), August’2025
Figure 11-4: Nucynta ER - Available Dosage Strengths (mg)
Figure 11-5: Nucynta ER - Price Per Unit & Supply (US$), August’2025
Figure 11-6: Global - Nucynta ER Annual Sales (US$ Million), 2020-2025
Figure 11-7: Global - Nucynta ER Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 11-8: Global - Nucynta ER Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 11-9: Kadian - Available Dosage Strengths (mg)
Figure 11-10: Kadian - Price Per Unit & Supply Of Strength 10 mg/12 hr (US$), August’2025
Figure 11-11: Kadian - Price Per Unit & Supply Of Strength 10 mg/12 to 24 hr & 10 mg/24 hr (US$), August’2025
Figure 11-12: Kadian - Price Per Unit & Supply Of Strength 20 mg/12 hr (US$), August’2025
Figure 11-13: Kadian - Price Per Unit & Supply Of Strength 20 mg/12 to 24 hr & 20 mg/24 hr (US$), August’2025
Figure 11-14: Kadian - Price Per Unit & Supply Of Strength 30 mg/12 hr (US$), August’2025
Figure 11-15: Kadian - Price Per Unit & Supply Of Strength 30 mg/12 to 24 hr & 30 mg/24 hr (US$), August’2025
Figure 11-16: Kadian - Price Per Unit & Supply Of Strength 40 mg/12 to 24 hr & 40 mg/24 hr (US$), August’2025
Figure 11-17: Kadian - Price Per Unit & Supply Of Strength 50 mg/12 hr (US$), August’2025
Figure 11-18: Kadian - Price Per Unit & Supply Of Strength 50 mg/12 to 24 hr & 50 mg/24 hr (US$), August’2025
Figure 11-19: Kadian - Price Per Unit & Supply Of Strength 60 mg/12 hr (US$), August’2025
Figure 11-20: Kadian - Price Per Unit & Supply Of Strength 60 mg/12 to 24 hr (US$), August’2025
Figure 11-21: Kadian - Price Per Unit & Supply Of Strength 60 mg/24 hr (US$), August’2025
Figure 11-22: Kadian - Price Per Unit & Supply Of Strength 70 mg/12 to 24 hr (US$), August’2025
Figure 11-23: Kadian - Price Per Unit & Supply Of Strength 80 mg/12 hr, 80 mg/12 to 24 hr & 80 mg/24 hr (US$), August’2025
Figure 11-24: Kadian - Price Per Unit & Supply Of Strength 100 mg/12 hr, 100 mg/12 to 24 hr & 100 mg/24 hr (US$), August’2025
Figure 11-25: Kadian - Price Per Unit & Supply Of Strength 130 mg/12 to 24 hr & 150 mg/12 to 24 hr (US$), August’2025
Figure 11-26: Kadian - Price Per Unit & Supply Of Strength 200 mg/12 to 24 hr & 200 mg/24 hr (US$), August’2025
Figure 11-27: Xtampza ER - Available Dosage Strengths (mg)
Figure 11-28: Xtampza ER - Price Per Unit & Supply (US$), August’2025
Figure 11-29: Global - Xtampza ER Annual Sales (US$ Million), 2020-2025
Figure 11-30: Global - Xtampza ER Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 11-31: Global - Xtampza ER Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 11-32: MS Contin - Available Dosage Strengths (mg)
Figure 11-33: MS Contin - Price Per Unit & Supply (US$), August’2025
Figure 11-34: Embeda - Price Per Unit & Supply (US$), August’2025
Figure 11-35: Zynrelef - Price Per Unit & Supply (US$), August’2025
Figure 11-36: Global - Zynrelef Annual Sales (US$ Million), 2021-2025
Figure 11-37: Global - Zynrelef Quarterly Sales (US$ Million), H1’2025
Figure 11-38: Global - Zynrelef Quarterly Sales (US$ Million), 2024
Figure 11-39: ConZip - Available Dosage Strengths (mg)
Figure 11-40: ConZip - Price Per Unit & Supply (US$), August’2025
Figure 11-41: Generic Hydromorphone - Available Dosage Strengths (mg)
Figure 11-42: Generic Hydromorphone - Price Per Unit & Supply (US$), August’2025
Figure 12-1: Ampyra - Price Per Unit & Supply (US$), August’2025
Figure 12-2: Generic Dalfampridine - Price Per Unit & Supply (US$), August’2025
Figure 12-3: ROW - Fampyra Annual Sales (US$ Million), 2020-2025
Figure 12-4: ROW - Fampyra Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-5: Tecfidera - Available Dosage Strengths (mg)
Figure 12-6: Tecfidera - Price Per Unit & Supply (US$), August’2025
Figure 12-7: Generic Dimethyl Fumarate - Price Per Unit & Supply (US$), August’2025
Figure 12-8: Global - Tecdifera Annual Sales (US$ Million), 2020-2025
Figure 12-9: Global - Tecdifera Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 12-10: Global - Tecdifera Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-11: US - Tecdifera Annual Sales (US$ Million), 2020-2025
Figure 12-12: US - Tecdifera Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 12-13: US - Tecdifera Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-14: ROW - Tecdifera Annual Sales (US$ Million), 2020-2025
Figure 12-15: ROW - Tecdifera Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 12-16: ROW - Tecdifera Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-17: Vumerity - Price Per Unit & Supply (US$), August’2025
Figure 12-18: Global - Vumerity Annual Sales (US$ Million), 2020-2025
Figure 12-19: Global - Vumerity Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 12-20: Global - Vumerity Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-21: US - Vumerity Annual Sales (US$ Million), 2020-2025
Figure 12-22: US - Vumerity Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 12-23: US - Vumerity Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-24: ROW - Vumerity Annual Sales (US$ Million), 2020-2025
Figure 12-25: ROW - Vumerity Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 12-26: ROW - Vumerity Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 12-27: Rayos - Available Dosage Strengths (mg)
Figure 12-28: Rayos - Price Per Unit & Supply (US$), August’2025
Figure 12-29: US - Rayos Annual Sales (US$ Million), 2020-2023
Figure 12-30: Global - Rayos Quarterly Sales (US$ Million), H1’2023
Figure 12-31: Bafiertam - Price Per Unit & Supply (US$), August’2025
Figure 13-1: Glumetza - Available Dosage Strengths (mg)
Figure 13-2: Glumetza - Price Per Unit & Supply (US$), August’2025
Figure 13-3: Generic Metformin - Price Per Unit & Supply Of 500mg (US$), August’2025
Figure 13-4: Generic Metformin - Price Per Unit & Supply Of 1000mg (US$), August’2025
Figure 13-5: Glucotrol XL - Available Dosage Strengths (mg)
Figure 13-6: Glucotrol XL - Price Per Unit & Supply Of Strength 5 mg (US$), August’2025
Figure 13-7: Glucotrol XL - Price Per Unit & Supply Of Strength 10 mg (US$), August’2025
Figure 13-8: Generic Glipizide - Price Per Unit & Supply Of Strength 5 mg (US$), August’2025
Figure 13-9: Generic Glipizide - Price Per Unit & Supply Of Strength 10 mg (US$), August’2025
Figure 13-10: Glucophage XR - Available Dosage Strengths (mg)
Figure 13-11: Glucophage XR - Price Per Unit & Supply Of Strength 10 mg (US$), August’2025
Figure 13-12: Glucophage XR - Price Per Unit & Supply Of Strength 750 mg (US$), August’2025
Figure 13-13: Trijardy XR - Price Per Unit & Supply Of Strengths 10 mg-5 mg-1000 mg & 25 mg-5 mg-1000 mg (US$), August’2025
Figure 13-14: Trijardy XR - Price Per Unit & Supply Of Strengths 10 mg-5 mg-1000 mg & 25 mg-5 mg-1000 mg (US$), August’2025
Figure 13-15: Synjardy XR - Price Per Unit & Supply Of 10 mg-1000 mg & 25 mg-1000 mg (US$), August’2025
Figure 13-16: Synjardy XR - Price Per Unit & Supply Of 5 mg-1000 mg & 12.5 mg-1000 mg (US$), August’2025
Figure 14-1: Procardia XL - Available Dosage Strengths (mg)
Figure 14-2: Procardia XL - Price Per Unit & Supply Of 100 Tablets (US$), August’2025
Figure 14-3: Procardia XL - Price Per Unit & Supply Of 300 Tablets (US$), August’2025
Figure 14-4: Toprol XL - Available Dosage Strengths
Figure 14-5: Toprol XL - Price Per Unit & Supply Of Strengths 25 mg, 50 mg & 200 mg (US$), August’2025
Figure 14-6: Toprol XL - Price Per Unit & Supply Of Strengths 100 mg (US$), August’2025
Figure 14-7: Global - Toprol XL Annual Sales (US$ Million), 2020-2024
Figure 14-8: Global - Toprol XL Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 14-9: US - Toprol XL Annual Sales (US$ Million), 2020-2024
Figure 14-10: EU - Toprol XL Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 14-11: EU - Toprol XL Annual Sales (US$ Million), 2020-2024
Figure 14-12: EU - Toprol XL Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 14-13: ROW - Toprol XL Annual Sales (US$ Million), 2020-2024
Figure 14-14: ROW - Toprol XL Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 14-15: Verelan PM - Available Dosage Strengths (mg)
Figure 14-16: Verelan PM - Price Per Unit & Supply (US$), August’2025
Figure 14-17: Generic Verapamil - Price Per Unit & Supply (US$), August’2025
Figure 14-18: Cardizem LA - Available Dosage Strengths (mg)
Figure 14-19: Cardizem LA - Price Per Unit & Supply Of 30 Tablets (US$), August’2025
Figure 14-20: Cardizem LA - Price Per Unit & Supply Of 90 Tablets (US$), August’2025
Figure 14-21: Calan SR - Available Dosage Strengths (mg)
Figure 14-22: Calan SR - Price Per Unit & Supply Of 120 mg & 180 mg (US$), August’2025
Figure 14-23: Calan SR - Price Per Unit & Supply Of 240 mg (US$), August’2025
Figure 14-24: Altoprev - Available Dosage Strengths (mg)
Figure 14-25: Altoprev - Price Per Unit & Supply (US$), August’2025
Figure 14-26: Cardura XL - Available Dosage Strengths (mg)
Figure 14-27: Cardura XL - Price Per Unit & Supply (US$), August’2025
Figure 15-1: Apretude - Price Per Unit & Supply (US$), August’2025
Figure 15-2: Cabenuva - Price Per Unit & Supply (US$), August’2025
Figure 15-3: Rukobia - Price Per Unit & Supply (US$), August’2025
Figure 16-1: Qelbree - Price Per Unit & Supply Of Strengths 100 mg & 150 mg (US$), August’2025
Figure 16-2: Qelbree - Price Per Unit & Supply Of Strength 200 mg (US$), August’2025
Figure 16-3: Global - Qelbree Annual Sales (US$ Million), 2021-2023
Figure 16-4: Global - Qelbree Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 16-5: Global - Qelbree Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 16-6: Jornay PM - Available Dosage Strengths (mg)
Figure 16-7: Jornay PM - Price Per Unit & Supply (US$), August’2025
Figure 16-8: Global - Jornay PM Annual Sales (US$ Million), 2024-2025
Figure 16-9: Global - Jornay PM Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 16-10: Global - Jornay PM Quarterly Sales (US$ Million), Q3-Q4’2024
Figure 16-11: Cotempla XR-ODT - Available Dosage Strengths (mg)
Figure 16-12: Cotempla XR-ODT - Price Per Unit & Supply (US$), August’2025
Figure 16-13: Adzenys XR-ODT - Available Dosage Strengths (mg)
Figure 16-14: Adzenys XR-ODT - Price Per Unit & Supply (US$), August’2025
Figure 16-15: Global - Adzenys XR-ODT & Cotempla XR-ODT Annual Sales (US$ Million), 2021-2025
Figure 16-16: Global - Adzenys XR-ODT & Cotempla XR-ODT Quarterly Sales (US$ Million), Q1’2025
Figure 16-17: Global - Adzenys XR-ODT & Cotempla XR-ODT Quarterly Sales (US$ Million), Q1-Q4’2025
Figure 16-18: Intuniv - Available Dosage Strengths (mg)
Figure 16-19: Intuniv - Price Per Unit & Supply (US$), August’2025
Figure 16-20: Global - Intuniv Annual Sales (US$ Million), 2020-2025
Figure 16-21: Global - Intuniv Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 16-22: Focalin XR - Available Dosage Strengths (mg)
Figure 16-23: Focalin XR - Price Per Unit & Supply (US$), August’2025
Figure 17-1: Rinvoq - Available Dosage Strengths (mg)
Figure 17-2: Rinvoq - Price Per Unit & Supply (US$), August’2025
Figure 17-3: Global - Rinvoq Annual Sales (US$ Million), 2020-2025
Figure 17-4: Global - Rinvoq Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 17-5: Global - Rinvoq Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 17-6: US - Rinvoq Annual Sales (US$ Million), 2020-2025
Figure 17-7: US - Rinvoq Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 17-8: US - Rinvoq Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 17-9: ROW - Rinvoq Annual Sales (US$ Million), 2020-2025
Figure 17-10: ROW - Rinvoq Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 17-11: ROW - Rinvoq Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 17-12: Ortikos - Available Dosage Strengths (mg)
Figure 17-13: Ortikos - Price Per Unit & Supply (US$), August’2025
Figure 17-14: Xeljanz XR - Available Dosage Strengths (mg)
Figure 17-15: Xeljanz XR - Price Per Unit & Supply (US$), August’2025
Figure 17-16: Global - Xeljanz XR Annual Sales (US$ Million), 2020-2025
Figure 17-17: Global - Xeljanz XR Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 17-18: Global - Xeljanz XR Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 17-19: US - Xeljanz XR Annual Sales (US$ Million), 2020-2025
Figure 17-20: US - Xeljanz XR Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 17-21: US - Xeljanz XR Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 17-22: ROW - Xeljanz XR Annual Sales (US$ Million), 2020-2025
Figure 17-23: ROW - Xeljanz XR Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 17-24: ROW - Xeljanz XR Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 17-25: Mestinon Timespan - Price Per Unit & Supply (US$), August’2025
Figure 17-26: Generic Pyridostigmine - Price Per Unit & Supply (US$), August’2025
Figure 17-27: Symax Duotab - Price Per Unit & Supply (US$), August’2025
Figure 18-1: Aemcolo - Price Per Unit & Supply (US$), August’2025
Figure 18-2: Talicia - Price Per Unit & Supply (US$), August’2025
Figure 19-1: Sublocade - Price Per Unit & Supply (US$), August’2025
Figure 19-2: Global - Sublocade Annual Sales (US$ Million), 2020-2025
Figure 19-3: Global - Sublocade Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 19-4: Global - Sublocade Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 19-5: Sublocade - Price Per Unit & Supply Of Strength 50 mg/mL (US$), August’2025
Figure 19-6: Sublocade - Price Per Unit & Supply Of Strength 355.6 mg/mL (US$), August’2025
Figure 20-1: Astagraf XL - Available Dosage Strengths (mg)
Figure 20-2: Astagraf XL - Price per Unit & Supply (US$), August’2025
Figure 20-3: Envarsus XR - Available Dosage Strengths (mg)
Figure 20-4: Envarsus XR - Price per Unit & Supply Of 30 Tablets (US$), August’2025
Figure 20-5: Envarsus XR - Price per Unit & Supply Of 100 Tablets (US$), August’2025
Figure 21-1: Trokendi XR - Available Dosage Strengths (mg)
Figure 21-2: Trokendi XR - Price per Unit & Supply (US$), August’2025
Figure 21-3: Global - Trokendi XR Annual Sales (US$ Million), 2020-2025
Figure 21-4: Global - Trokendi XR Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 21-5: Global - Trokendi XR Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 21-6: Global - Oxtellar XR Annual Sales (US$ Million), 2020-2025
Figure 21-7: Global - Oxtellar XR Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 21-8: Global - Oxtellar XR Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 21-9: Keppra XR - Available Dosage Strengths (mg)
Figure 21-10: Keppra XR - Price per Unit & Supply (US$), August’2025
Figure 21-11: Generic levetiracetam - Price per Unit & Supply Of 500 mg (US$), August’2025
Figure 21-12: Keppra XR - Price per Unit & Supply (US$), August’2025
Figure 21-13: Global - Oxtellar XR Annual Sales (US$ Million), 2020-2025
Figure 21-14: Roweepra XR - Available Dosage Strengths (mg)
Figure 21-15: Roweepra XR - Price per Unit & Supply (US$), August’2025
Figure 21-16: Depakote - Available Dosage Strengths (mg)
Figure 21-17: Depakote - Price per Unit & Supply (US$), August’2025
Figure 21-18: Depakote ER - Available Dosage Strengths (mg)
Figure 21-19: Depakote ER - Price per Unit & Supply (US$), August’2025
Figure 21-20: Depakote Sprinkles - Price per Unit & Supply (US$), August’2025
Figure 22-1: Effexor XR - Available Dosage Strengths (mg)
Figure 22-2: Effexor XR - Price per Unit & Supply Of 30 Capsules (US$), August’2025
Figure 22-3: Effexor XR - Price per Unit & Supply Of 90 Capsules (US$), August’2025
Figure 22-4: Generic Venlafaxine - Price per Unit & Supply Of 37.5 mg (US$), August’2025
Figure 22-5: Generic Venlafaxine - Price per Unit & Supply Of 37.5 mg (US$), August’2025
Figure 22-6: Generic Venlafaxine - Price per Unit & Supply Of 37.5 mg (US$), August’2025
Figure 22-7: Global - Effexor XR Annual Sales (US$ Million), 201-2025
Figure 22-8: Global - Effexor XR Quarterly Sales (US$ Million), Q1 & Q2’2025
Figure 22-9: Global - Effexor XR Quarterly Sales (US$ Million), Q1-Q4’2024
Figure 22-10: Xanax XR - Available Dosage Strengths (mg)
Figure 22-11: Xanax XR - Price per Unit & Supply (US$), August’2025
Figure 22-12: Generic Alprazolam - Price per Unit & Supply (US$), August’2025
Figure 22-13: Ambien CR - Available Dosage Strengths (mg)
Figure 22-14: Ambien CR - Price per Unit & Supply (US$), August’2025
Figure 22-15: Generic Zolpidem - Price per Unit & Supply Of 6.25 mg (US$), August’2025
Figure 22-16: Generic Zolpidem - Price per Unit & Supply Of 12.5 mg (US$), August’2025
Figure 23-1: Klor-Con 8 - Price per Unit & Supply (US$), August’2025
Figure 23-2: Generic Potassium Chloride - Price per Unit & Supply Of 8 mEq (US$), August’2025
Figure 23-3: Klor-Con 10 - Price per Unit & Supply (US$), August’2025
Figure 23-4: Klor-Con M10 - Price per Unit & Supply (US$), August’2025
Figure 23-5: Klor-Con M15 - Price per Unit & Supply (US$), August’2025
Figure 23-6: Generic Potassium Chloride - Price per Unit & Supply Of 15 mEq (US$), August’2025
Figure 23-7: Klor-Con M20 - Price per Unit & Supply (US$), August’2025
Figure 24-1: Controlled Drug Delivery System Market - Key Drivers
Figure 24-2: Controlled Drug Delivery System Market - Major Challenges
